Valley Fever Vaccine Development Act

H.R. 5416, the Valley Fever Vaccine Development Act, would direct the Department of Health and Human Services to provide federal grants for the research and development of a vaccine against Valley Fever. By funding these efforts through the Centers for Disease Control and Prevention (CDC), the bill aims to accelerate the creation of a preventative medical solution for this fungal infection, which primarily affects residents and travelers in the southwestern United States. If enacted, the legislation would focus federal resources on reducing the public health impact and long-term respiratory complications associated with the disease.